Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -764.45%-4.69M | 897.75%2.26M | 34.73%-974.36K | -96.21%-2.15M | -70.66%172.27K | -74.25%-542.47K | -136.99%-283.49K | -19.41%-1.49M | -26.72%-1.09M | -31.34%587.08K |
| Net income from continuing operations | -539.52%-2.5M | -346.03%-769.38K | 71.10%-266.78K | -123.17%-3.42M | -141.89%-1.93M | -68.02%-391.38K | -6.21%-172.5K | -173.17%-923.19K | 13.14%-1.53M | 16.47%-798.05K |
| Asset impairment expenditure | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Remuneration paid in stock | --2.03M | --180.79K | -89.25%70.69K | 1,513.36%2.08M | --1.42M | --0 | --0 | 705.03%657.56K | -51.54%128.62K | --0 |
| Deferred tax | ---- | ---- | ---- | 19.91%1.14M | ---- | ---- | ---- | ---- | -45.51%948.18K | ---- |
| Other non cashItems | ---- | ---- | ---- | -121.66%-1.31M | ---- | ---- | ---- | ---- | 50.04%-592.99K | ---- |
| Change In working capital | -2,688.94%-4.21M | 2,667.88%2.85M | 36.58%-778.27K | -1,248.49%-626.81K | -16.26%862.52K | -20.57%-151.1K | -359.44%-110.99K | -23.48%-1.23M | -157.29%-46.48K | -21.19%1.03M |
| -Change in receivables | -185.55%-396.79K | -3,843.71%-207.63K | 1,538.61%210.8K | -1,365.35%-224.42K | -165.02%-76.36K | -55.20%-138.96K | 111.23%5.55K | -137.38%-14.65K | 203.40%17.74K | -32.53%117.44K |
| -Change in prepaid assets | 129.53%11.17K | -17,835.76%-560.98K | 126.88%26.89K | -191.38%-135.32K | -118.94%-648 | -149.23%-37.8K | -97.85%3.16K | 44.98%-100.03K | -310.43%-46.44K | -98.67%3.42K |
| -Change in payables and accrued expense | -15,019.08%-3.83M | 3,123.16%3.62M | 8.68%-1.02M | -1,402.24%-267.07K | 3.35%939.53K | 224.44%25.66K | -117.79%-119.7K | -30.69%-1.11M | -123.32%-17.78K | 3.86%909.09K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -764.45%-4.69M | 897.75%2.26M | 34.73%-974.36K | -96.21%-2.15M | -70.66%172.27K | -74.25%-542.47K | -136.99%-283.49K | -19.41%-1.49M | -26.72%-1.09M | -31.34%587.08K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -889.24%-5.41M | -70.75%-8.77M | 77.64%-103.89K | -40.49%-7.12M | -100.81%-2.2M | 132.13%685.06K | -223.40%-5.14M | -85.30%-464.65K | 34.99%-5.07M | 54.58%-1.1M |
| Net PPE purchase and sale | 1,208.81%8.84M | -70.98%-8.76M | 77.64%-103.89K | -36.70%-6.93M | -83.86%-2.02M | 131.67%675.37K | -222.25%-5.12M | -86.57%-464.65K | 34.99%-5.07M | 54.58%-1.1M |
| Net other investing changes | -147,118.83%-14.25M | ---- | ---- | -11,359.42%-194.58K | ---186.1K | --9.69K | ---- | ---- | 23.20%-1.7K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -889.24%-5.41M | -70.75%-8.77M | 77.64%-103.89K | -40.49%-7.12M | -100.81%-2.2M | 132.13%685.06K | -223.40%-5.14M | -85.30%-464.65K | 34.99%-5.07M | 54.58%-1.1M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -31.53%3.81M | 290.76%14.06M | 122.77%590.97K | 72.31%16.53M | 77.25%7.11M | 2.12%5.56M | 2,470.12%3.6M | 265.28K | 21.22%9.59M | 25.96%4.01M |
| Net issuance payments of debt | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Net common stock issuance | -31.53%3.81M | 290.76%14.06M | 122.77%590.97K | 72.31%16.53M | 77.25%7.11M | 2.12%5.56M | 2,470.12%3.6M | --265.28K | 20.61%9.59M | 24.40%4.01M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -31.53%3.81M | 290.76%14.06M | 122.77%590.97K | 72.31%16.53M | 77.25%7.11M | 2.12%5.56M | 2,470.12%3.6M | --265.28K | 21.22%9.59M | 25.96%4.01M |
| Net cash flow | ||||||||||
| Beginning cash position | 402.32%22.27M | 135.26%14.72M | 91.31%15.21M | 75.83%7.95M | 127.68%10.13M | 205.41%4.43M | 107.18%6.26M | 75.83%7.95M | -14.20%4.52M | 53.50%4.45M |
| Current changes in cash | -210.33%-6.29M | 513.72%7.55M | 71.20%-487.29K | 111.72%7.26M | 45.03%5.07M | 90.07%5.7M | -16.29%-1.82M | -12.75%-1.69M | 558.26%3.43M | 115.78%3.5M |
| End cash Position | 57.66%15.98M | 402.32%22.27M | 135.26%14.72M | 91.31%15.21M | 91.31%15.21M | 127.68%10.13M | 205.41%4.43M | 107.18%6.26M | 75.83%7.95M | 75.83%7.95M |
| Free cash from | 3,022.63%4.15M | -20.16%-6.49M | 44.92%-1.08M | -47.27%-9.07M | -261.61%-1.85M | 105.44%132.9K | -216.28%-5.4M | -30.57%-1.96M | 28.84%-6.16M | 67.31%-510.31K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.